TrueBlue, Inc.(TBI)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
TBI has no upcoming report date in the calendar yet. It last reported on Nov 4, 2026; companies usually report every three months.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±12.9%).
Did the stock rise after good news?
The next-day move after each of its last 9 EPS beats and 3 misses.
In plain words: it beat expectations 9 times, but the stock still fell 5 of those 9 times.
- Nov '26Beat▲ +25.6%
- Aug '26Beat▲ +28.7%
- May '26Beat▲ +0.2%
- Feb '26Missed▼ -13.5%
- Nov '25Beat▲ +17.3%
- Aug '25Beat▼ -3.9%
- May '25Missed▼ -10.5%
- Feb '25Beat▼ -15.0%
- Nov '24Beat▼ -4.3%
- Aug '24Missed▼ -24.4%
- May '24Beat▼ -0.3%
- Feb '24Beat▼ -11.2%
Clear beats and misses with a known reaction only. What counts as a beat
Why did TBI fall after beating earnings?
5 of TBI's last 12 reactions went against the EPS result. What stands out in each:
TBI beat EPS estimates in 9 quarters, and the stock still closed lower the next day 5 times.
- Aug 4, 2025EPS beat +30.0%stock -3.9% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
- Feb 19, 2025EPS beat +87.5%stock -15.0% next day
- It opened 5.5% higher, but sellers took over and it closed -15.0%.
- Nov 4, 2024EPS beat +26.7%stock -4.3% next day
- It opened 5.1% higher, but sellers took over and it closed -4.3%.
- May 6, 2024EPS beat +108.1%stock -0.3% next day
- It opened 3.9% higher, but sellers took over and it closed -0.3%.
- Feb 21, 2024EPS beat +33.3%stock -11.2% next day
- It opened 3.0% higher, but sellers took over and it closed -11.2%.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was TBI's earnings move already priced in?
TBI's move in the month before each of its last 12 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 12 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does TBI hold its opening gap after earnings?
TBI's opening move after each report and where it closed that day.
In 11 reports TBI opened at least 1% away from the previous close. It gave back half or more of that gap by the close 5 of 11 times (46%), and fully reversed 4 times. Gaps up faded 5 of 8; gaps down recovered 0 of 3.
- Nov 4, 2026HeldOpened +37.0%, closed +25.6%
- Aug 4, 2026HeldOpened +20.8%, closed +28.7%
- May 5, 2026FadedOpened +8.3%, closed +0.2%
- Feb 18, 2026HeldOpened -15.9%, closed -13.5%
- Nov 3, 2025HeldOpened +2.8%, closed +17.3%
- May 5, 2025HeldOpened -9.3%, closed -10.5%
- Feb 19, 2025ReversedOpened +5.5%, closed -15.0%
- Nov 4, 2024ReversedOpened +5.1%, closed -4.3%
What the history says
- TBI has beaten EPS estimates in 3 straight quarters.
- It fell after 5 of its 9 EPS beats (56%): beating estimates has not been enough on its own.
TBI earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | Revenue surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | After close | $0.19 | $0.33 | +73.7% | +13.1% | +25.61% | — |
| Aug 4, 2026 | After close | -$0.10 | $0.06 | +160.0% | — | +28.74% | +32.64% |
| May 5, 2026 | After close | -$0.45 | -$0.41 | +8.9% | — | +0.17% | -7.12% |
| Feb 18, 2026 | After close | -$0.05 | -$0.25 | -400.0% | — | -13.50% | -19.03% |
| Nov 3, 2025 | After close | -$0.08 | $0.03 | +137.5% | — | +17.31% | +7.91% |
| Aug 4, 2025 | After close | -$0.10 | -$0.07 | +30.0% | — | -3.94% | -4.42% |
| May 5, 2025 | After close | -$0.32 | -$0.40 | -25.0% | — | -10.49% | -0.47% |
| Feb 19, 2025 | After close | -$0.16 | -$0.02 | +87.5% | — | -15.03% | -17.85% |
| Nov 4, 2024 | After close | -$0.15 | -$0.11 | +26.7% | — | -4.31% | +5.48% |
| Aug 5, 2024 | After close | -$0.02 | -$0.35 | -1650.0% | — | -24.37% | -24.84% |
| May 6, 2024 | After close | -$0.37 | $0.03 | +108.1% | — | -0.28% | +5.48% |
| Feb 21, 2024 | After close | $0.06 | $0.08 | +33.3% | — | -11.18% | -8.21% |
TBI Earnings FAQ
Answers computed from TrueBlue, Inc.'s reported history
TBI has no upcoming report date in the calendar yet. It last reported on Nov 4, 2026; companies usually report every three months.
Over the last 12 quarters with a usable EPS surprise, TBI beat the consensus estimate 9 times (75%), missed 3 and landed in line 0. It has beaten estimates in each of the last 3 counted quarters.
Across its last 12 quarters with a measured reaction, TBI moved an average of ±12.9% in the first session after reporting. It closed higher 33% of the time; the largest gain was 28.7% and the largest drop -24.4%.
TBI fell in the first session after 5 of its last 9 EPS beats (56%). A beat that was already priced in, or weaker guidance, can send a stock lower.
Across its last 12 quarters with price data, TBI moved an average of -1.3% in the 20 trading sessions before reporting and was higher in 33% of them. After a run-up of 3% or more (4 quarters), it fell the next day 50% of the time, averaging -0.7%. After a drop of 3% or more (8 quarters), it rose the next day 25% of the time, averaging -1.0%. This describes past reports; it is not a forecast.
In 11 reports TBI opened at least 1% away from the previous close. It gave back half or more of that gap by the close 5 of 11 times (46%), and fully reversed 4 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · TBI: 12 reported quarters, latest Nov 4, 2026. Information only, not investment advice.
Looking for more on TBI?
Price charts, forecast, fundamentals and risk pages for TBI are not on Tickzen yet. You can run a full stock analysis now.
Run the TBI Stock AnalyzerLatest TickZen Insights
AbbVie (ABBV) Q3 2026 Earnings Preview: Will Skyrizi and Rinvoq be able to justify the 20x?By Vishal Jadaun
Alphabet (GOOG) Q3 2026 Earnings Preview: Will Cloud Overtake Capex?By Vishal Jadaun
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun